Whole-Body Inhalation Exposure System

Overview

The Whole-Body Inhalation Exposure System is a precision-engineered, regulatory-compliant platform designed for controlled, reproducible delivery of airborne test agents—including gases, vapors, aerosols, and particulates—to laboratory animals under conscious, unrestrained conditions. Based on the principle of dynamic flow-through chamber exposure, the system maintains stable, real-time control of environmental parameters (e.g., airflow rate, temperature, relative humidity, and test atmosphere concentration) to ensure physiologically relevant dosimetry. It supports both acute and subchronic exposure regimens in compliance with OECD Test Guidelines 412 (Subacute Inhalation Toxicity), 413 (Subchronic Inhalation Toxicity), and ASTM E1705 (Standard Practice for Conducting Whole-Body Inhalation Studies in Rodents), making it suitable for GLP-certified laboratories conducting safety assessment studies for pharmaceuticals, agrochemicals, industrial chemicals, and nanomaterials.

Key Features

• Modular stainless-steel or polycarbonate exposure chambers accommodating rodents (mice, rats) or larger species (e.g., guinea pigs, rabbits) in group or individual configurations
• Integrated mass flow controllers (MFCs) and dilution air systems enabling precise control of test atmosphere concentration (ppm, mg/m³, or particle number/cm³) across wide dynamic ranges
• Real-time monitoring of chamber environmental parameters—temperature (±0.5 °C), relative humidity (±3% RH), and oxygen levels—with automated feedback regulation
• HEPA- and carbon-filtered exhaust handling with optional sampling ports for gravimetric, chemical, or particle-size distribution analysis (e.g., via cascade impactor or SMPS)
• Compliance-ready architecture supporting audit trails, user access levels, and electronic record retention per FDA 21 CFR Part 11 requirements when paired with validated software
• Flexible integration with aerosol generators (e.g., nebulizers, dry powder dispersers, vaporizers) and real-time analyzers (FTIR, GC-MS, CPC)

Sample Compatibility & Compliance

The system accommodates a broad spectrum of test atmospheres: volatile organic compounds (VOCs), combustion-derived particulates, engineered nanoparticles, bioaerosols (bacterial endotoxins, viral surrogates), pesticide formulations, and respiratory therapeutic aerosols. Chamber design adheres to ISO 16142-1:2020 (principles of risk management for medical devices) and supports alignment with ICH S5(R3) guidelines for reproductive toxicity testing. All wetted materials are USP Class VI-certified; gasketing and seals comply with FDA 21 CFR 177.2600 for repeated-use exposure applications. System validation protocols include chamber homogeneity mapping (per ASTM D6825), leak integrity testing (≤1% volume loss/hour at 25 Pa differential), and aerosol deposition uniformity verification (RSD <15% across chamber zones).

Software & Data Management

Control and data acquisition are managed via a dedicated Windows-based application featuring configurable exposure schedules (start/stop times, ramp profiles, multi-phase protocols), live parameter dashboards, and synchronized logging at ≤1 Hz resolution. The software supports CSV and XML export formats compatible with toxicokinetic modeling tools (e.g., PBPK platforms such as GastroPlus or Simcyp). Audit trail functionality records all operator actions, parameter changes, and alarm events with timestamps and user IDs. For regulated environments, optional 21 CFR Part 11 modules provide electronic signatures, role-based permissions, and immutable archive generation—fully traceable during regulatory inspections (EPA, EMA, PMDA).

Applications

• Preclinical inhalation toxicology studies supporting IND/NDA submissions
• Respiratory disease modeling (COPD, asthma, pulmonary fibrosis) using allergen or irritant challenge protocols
• Occupational health risk assessment of workplace airborne hazards (e.g., welding fumes, silica dust, diesel exhaust)
• Evaluation of inhaled drug delivery efficiency and regional deposition patterns in translational models
• Environmental health research on ambient air pollutants (PM₂.₅, ozone co-exposures) and climate-relevant aerosols
• Regulatory testing for biocidal products, plant protection agents, and nanomaterials under EU REACH and US EPA TSCA frameworks

FAQ

What species and cage configurations are supported?
Standard configurations support up to 20 mice or 10 rats per chamber; custom modular racks enable parallel exposures across multiple dose groups. Larger chambers for rabbits or non-human primates are available upon engineering review.
Can the system be validated for GLP studies?
Yes—the system includes IQ/OQ documentation templates, and third-party qualification services (including PQ execution) are available through authorized partners accredited to ISO/IEC 17025.
Is real-time aerosol concentration monitoring integrated?
While core hardware does not include embedded analyzers, standardized analog/digital I/O interfaces allow seamless integration with commercial real-time monitors (e.g., TSI APS, Grimm EDM 180, Thermo Scientific pDR series).
How is animal welfare addressed during exposure?
Chambers meet NIH Guide for Care and Use of Laboratory Animals criteria: continuous O₂ monitoring (alarm threshold: <19.5%), CO₂ scrubbing capability, and ≥12 air changes/hour minimum ventilation to prevent hypercapnia or thermal stress.
Does the system support nose-only exposure as well?
This model is optimized for whole-body exposure; however, compatible nose-only restraint modules and auxiliary flow manifolds can be supplied as add-on kits for comparative route-of-exposure studies.